Evolus Inc (EOLS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Evolus Inc   (NASDAQ: EOLS)


Evolus Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Evolus Inc's ROI in the second quarter of 2026?
Evolus Inc recorded a cumulative net loss of $-34 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -22.71%.

Within the Healthcare sector 277 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3377 to 3442.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -8.45 % -8.1 % -10.38 % -3.66 % 6.69 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 149 153 151 152 165
Return On Investment (TTM) -22.71 % -27.99 % -33.05 % -36.37 % -37.54 %
EOLS's Overall Ranking # 3442 # 3377 # 2635 # 1762 # 3088
Seq. Investment Change TTM -2.54 % -0.72 % -2.96 % -2.5 % -2.16 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -34 -43 -52 -59 -62

EOLS Company Profile >> Back to EOLS Roi Comparisons >> See Annual EOLS Return On Investment



Return On Investment EOLS's Ranking
Within: No.
Industry # 101
Sector # 278
Overall # 3442

Return On Investment Statistics
High Average Low
-4.09 %
-39.75 %
-101.5 %
(Mar 31 2018)   (Sep 30 2021)



  News about Evolus Inc Return on Investment ROI

Evolus Unveils Nareg Sagherian as VP, Taking the Helm to Revitalize Investor Relations and Corporate Communications

January 4, 2024


Introduction
Evolus Inc., a performance beauty company dedicated to developing a robust aesthetic portfolio of consumer brands, has recently announced the appointment of Nareg Sagherian as Vice President, Head of Global Investor Relations and Corporate Communications. With an immense expertise in the field, Sagherian s arrival heralds a new era for Evolus as it strives to engage with current and prospective investors and foster a strategic investor relations and corporate communications program. This strategic move comes at a crucial time for the company, as it looks to address its net loss and improve its return on investment (ROI) figures.
Enhancing Investor Relations
One of the primary responsibilities of Nareg Sagherian in this new role will be to proactively engage and establish meaningful relationships with both current and potential investors. By leveraging his in-depth understanding of the financial markets and investor community, Sagherian aims to foster a culture of transparency and open communication with investors.





Financial Statements
Evolus Inc's II. Quarter Investments $ 149 Millions EOLS's Balance sheet
Evolus Inc's II. Quarter Income $ -8 Millions Quarterly EOLS's Income Statement
EOLS's Income by Division See EOLS's Income by Division


EOLS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 151 170 141 131 200
Y / Y Investment Growth -11.23 % 20.54 % 7.02 % -34.2 % 593.34 %
Net Income in Millions -52 -50 -62 -74 -47
Y / Y Net Income Growth - - - - -
Annual Return On Investment -34.3 % -29.73 % -43.84 % -56.6 % -23.43 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EOLS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EOLS's Competitors
Subscribers only: Roi for Evolus Inc's Suppliers
Subscribers only: Return On Investment for EOLS's Customers

Other Ratios
EOLS's Roa EOLS's Inventory Turnover Ratio EOLS's Growth Rates EOLS's Dividend Statistics
EOLS's Profitability Ratios EOLS's Asset Turnover Ratio EOLS's Dividend Growth
EOLS's Roe EOLS's Valuation Ratios EOLS's Financial Strength Ratios EOLS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-09T22:37:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.